Home › Funds › Legion Partners Asset Management, LLC › LFCR

Legion Partners Asset Management, LLC position in LFCR

LIFECORE BIOMEDICAL INC · Health Care

Legion Partners Asset Management, LLC reported holding 4,461,823 shares of LFCR (LIFECORE BIOMEDICAL INC) in its Q2 2026 13F filing — a position valued at US$23.4M, representing 57.75% of its reported portfolio and ranking #1 among its reported holdings. Legion Partners Asset Management, LLC has disclosed LFCR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)4.46M sh
Reported value held$23.42M
Portfolio Weight57.75%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Legion Partners Asset Management, LLC's LFCR position evolved

Legion Partners Asset Management, LLC first disclosed a stake in LFCR in Q3 2023 at 2,940,340 shares (US$22.2M). The position peaked in Q4 2025 at 4,461,823 shares, worth US$36.5M. Across 12 filings, Legion Partners Asset Management, LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 8 time(s). The most recent filing (Q2 2026) shows 4,461,823 shares valued at US$23.4M. Notable position changes include a 49% increase in Q4 2024 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.94M $22.18M New
Q4 2023 2.94M $18.20M Hold
Q1 2024 2.95M $15.67M Hold
Q2 2024 2.97M $15.23M Add
Q3 2024 2.97M $14.63M Hold
Q4 2024 4.43M $32.93M Add
Q1 2025 4.43M $31.20M Hold
Q2 2025 4.43M $35.99M Hold
Q3 2025 4.46M $32.84M Add
Q4 2025 4.46M $36.50M Hold
Q1 2026 4.46M $16.60M Hold
Q2 2026 4.46M $23.42M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LFCR and 13F data

LFCR (LIFECORE BIOMEDICAL INC) is a Health Care company. 21 other funds we track also report a position in LFCR — the largest reported positions include WYNNEFIELD CAPITAL INC (US$24.7M), Greenhaven Road Investment Management, L.P. (US$16.8M), 325 CAPITAL LLC (US$15.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LFCR

All LFCR fund holders →

FAQ

How long has Legion Partners Asset Management, LLC held LFCR?

Legion Partners Asset Management, LLC has disclosed LFCR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Legion Partners Asset Management, LLC's current position in LFCR?

As of Q2 2026, Legion Partners Asset Management, LLC holds 4.46M shares of LFCR (LIFECORE BIOMEDICAL INC), valued at $23.42M, representing 57.75% of its reported portfolio and ranking #1.

Has Legion Partners Asset Management, LLC been buying or selling LFCR?

In the latest 13F filing (Q2 2026), Legion Partners Asset Management, LLC held unchanged its position in LFCR. The position peaked in Q4 2025 at 4.46M shares.

Which other funds hold LFCR?

Other major institutional holders of LFCR include WYNNEFIELD CAPITAL INC, Greenhaven Road Investment Management, L.P., 325 CAPITAL LLC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.